Changes over time in the use of aspirin in patients hospitalized with acute myocardial infarction (1975 to 1997): A population-based perspective

American Heart Journal

Volumn 144, Issue 2, 2002, Pages 259-268

  Jackson, Elizabeth A ^a   Sivasubramian, Ramya ^a   Spencer, Frederick A ^a   Yarzebski, Jorge ^a   Lessard, Darleen ^a   Gore, Joel M ^a   Goldberg, Robert J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; HEART FAILURE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036345750     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.123837     Document Type: Article

References (40)

1. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
3. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
4. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
5. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: A meta-analysis
6. Guidelines for the early management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction)
7. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee an Management of Acute Myocardial Infarction)
8. Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: Results from the MITRA and MIR studies
9. Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: A quality improvement demonstration project
10. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: Patterns of use and outcomes
11. Early and pre-discharge aspirin administration among patients with acute myocardial infarction: Current clinical practice and trends in the United States
12. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: Evidence for undertreatment in women and the elderly
13. Observations of the treatment of women in the United States with myocardial infarction: A report from the National Registry of Myocardial Infarction-I
14. Treatment of acute myocardial infarction and 30-day mortality among women and men
15. Incidence and case fatality rates of acute myocardial infarction (1975-1984): The Worcester Heart Attack Study
16. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease
17. A two-decades (1975 to 1995) long experience in the incidence, in- hospital and long-term case-fatality rates of acute myocardial infarction: A community-wide perspective
18. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: A community-wide perspective
19. Temporal trends in cardiogenic shock complicating acute myocardial infarction
20. The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study
21. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice?
22. Recent trends in acute coronary heart disease - Mortality, morbidity, medical care, and risk factors
23. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: Missed opportunities for prevention?
24. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction
25. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study
26. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction
27. Age-related differences in management of heart disease: A study of cardiac medication use in an older cohort
28. Presentations of acute myocardial infarction in men and women
29. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study
30. Aspirin therapy in diabetes
31. Effects of acetylsalicylic acid on renal function in patients with chronic heart failure
32. Angiotensin-converting enzyme inhibitors and renal function in heart failure
33. Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
34. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: A cohort study of 11,575 patients with coronary artery disease
35. Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction
36. Aspirin and the treatment of heart failure in the elderly
37. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization
38. Patterns of aspirin use in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
39. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects